lobbying_activities: 3336930

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3336930	9b7d7737-5189-44e9-924b-548750177d97	Q1	FAEGRE DRINKER BIDDLE & REATH LLP	12631	NATIONAL ASSOCIATION OF BOARDS OF PHARMACY	2025	first_quarter	PHA	Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act.	HOUSE OF REPRESENTATIVES,SENATE	30000		0	0	2025-04-16T12:53:05-04:00